glp-1 fda shortage GLP-1s Going Direct, How Novo and Lilly's DTC Strategy is Changing the Game for Patients and Plan Sponsors FDA, Lilly Score Win in

Scientists found that the venom of the Gila monster, a lizard that spends most of its time underground and only eats three to four times a year, had a hormone remarkably similar to human GLP-1 that didnt break down as quickly

The most common short-term effects were skin rash or itchy skin, inflammation of the thyroid (thyroiditis) or low thyroid hormones (hypothyroidism), and joint pain

Influenced pathways may include: COX enzymatic activity NF-B inflammatory signalling prostaglandin pathways These findings make BPC-157 a prime candidate for inflammation-related molecular research

Ongoing Physician Support: You're never alone

doi: 10.1080/1120009X.2023.2177808 117 YangYYuSLiuWZhuoYQuCZengY